Your session is about to expire
← Back to Search
Focused Ultrasound BBB Disruption for Glioblastoma
Study Summary
This trial is testing whether it's safe to break down the blood-brain barrier in people with glioblastoma who have had surgery and standard chemotherapy.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have trouble lying down and staying still for up to 4 hours in a small space, like an MRI machine, or you feel very anxious in small spaces.You have a serious, life-threatening disease.You have a heart condition that causes blood to flow abnormally.You need higher and higher doses of corticosteroids.You have a condition affecting the blood vessels in your brain or body.You are allergic to DEFINITY ultrasound contrast agent or perflutren.You have long-term lung problems.You are receiving other treatments like chemotherapy, gene therapy, or radiation therapy in addition to this clinical trial.You are taking blood thinners or other medications that increase the risk of bleeding within a certain period before starting the treatment.You have symptoms like a severe headache, feeling sick to your stomach, throwing up, feeling tired, and swelling in the back of your eye.Both men and women can participate.You have a history of severe allergic reactions or multiple allergies, including drug allergies, asthma, or hay fever.You have an infection in your head or throughout your body.You have a history of bleeding disorder or blood clotting problems, or you have experienced spontaneous bleeding from a tumor in the past.You have sleep apnea that is not being treated or controlled.You have already completed a full course of chemotherapy in the past.You are allergic to eggs or products made from eggs.You have experienced a mini-stroke (TIA) within the past month.
- Group 1: Focused Ultrasound (FUS) BBB Disruption
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment accept participants in the below-fifty age bracket?
"According to the terms of this scientific study, only individuals between 18 and 80 are eligible for enrollment. Conversely, 34 clinical trials exist specifically for those under 18 years old while 414 studies apply to seniors over 65."
Is enrollment currently available for this research endeavor?
"Information published on clinicaltrials.gov displays that this specific trial, which was first made available to the public in October 2018 and most recently updated in March 2022 is not currently recruiting participants. While it does not need volunteers presently, there are 440 other medical studies actively seeking individuals right now."
What criteria must patients meet in order to participate in this medical research?
"To be considered for this glioblastoma trial, applicants must fall between the age of 18 and 80. A maximum of 14 candidates will be accepted."
Share this study with friends
Copy Link
Messenger